Safety and immunogenicity of a mosaic vaccine booster against Omicron and other SARS-CoV-2 variants: a randomized phase 2 trial.

Autor: Kaabi NA; Sheikh Khalifa Medical City, SEHA, Abu Dhabi, UAE.; College of Medicine and Health Sciences, Khalifa University, Abu Dhabi, UAE., Yang YK; China National Biotec Group Company Limited, Beijing, China., Liang Y; The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China.; National Engineering Center for New Vaccine Research, Beijing, China., Xu K; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), Beijing, China., Zhang XF; The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China.; National Engineering Center for New Vaccine Research, Beijing, China., Kang Y; National Engineering Center for New Vaccine Research, Beijing, China.; Clinical Medicine Office, National Vaccine and Serum Institute (NVSI), Beijing, China., Jin YQ; The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China.; National Engineering Center for New Vaccine Research, Beijing, China., Hou JW; The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China.; National Engineering Center for New Vaccine Research, Beijing, China., Zhang J; The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China.; National Engineering Center for New Vaccine Research, Beijing, China., Yang T; China National Biotec Group Company Limited, Beijing, China., Hussein S; Sheikh Khalifa Medical City, SEHA, Abu Dhabi, UAE., ElDein MS; Sheikh Khalifa Medical City, SEHA, Abu Dhabi, UAE., Lei ZH; The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China.; National Engineering Center for New Vaccine Research, Beijing, China., Zhang H; The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China.; National Engineering Center for New Vaccine Research, Beijing, China., Shao S; The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China.; National Engineering Center for New Vaccine Research, Beijing, China., Liu ZM; The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China.; National Engineering Center for New Vaccine Research, Beijing, China., Liu N; The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China.; National Engineering Center for New Vaccine Research, Beijing, China., Zheng X; The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China.; National Engineering Center for New Vaccine Research, Beijing, China., Su JG; The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China.; National Engineering Center for New Vaccine Research, Beijing, China., Yang SS; National Engineering Center for New Vaccine Research, Beijing, China.; Clinical Medicine Office, National Vaccine and Serum Institute (NVSI), Beijing, China., Cong X; National Engineering Center for New Vaccine Research, Beijing, China.; Clinical Medicine Office, National Vaccine and Serum Institute (NVSI), Beijing, China., Tan Y; National Engineering Center for New Vaccine Research, Beijing, China.; Clinical Medicine Office, National Vaccine and Serum Institute (NVSI), Beijing, China., Lei W; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), Beijing, China., Gao XJ; Lanzhou Institute of Biological Products Company Limited, Lanzhou, China., Jiang Z; Beijing Key Tech Statistical Consulting Co., Ltd, Beijing, China., Wang H; Beijing Institute of Biological Products Company Limited, Beijing, China., Li M; China National Biotec Group Company Limited, Beijing, China., Mekki HM; Union 71, Abu Dhabi, UAE., Zaher W; G42 Healthcare, Abu Dhabi, UAE., Mahmoud S; G42 Healthcare, Abu Dhabi, UAE., Zhang X; China National Biotec Group Company Limited, Beijing, China., Qu C; China National Biotec Group Company Limited, Beijing, China., Liu DY; China National Biotec Group Company Limited, Beijing, China., Zhang J; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), Beijing, China., Yang M; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), Beijing, China., Eltantawy I; G42 Healthcare, Abu Dhabi, UAE., Xiao P; G42 Healthcare, Abu Dhabi, UAE., Shen FJ; The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China.; National Engineering Center for New Vaccine Research, Beijing, China., Wu JJ; The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China.; National Engineering Center for New Vaccine Research, Beijing, China., Han ZB; The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China.; National Engineering Center for New Vaccine Research, Beijing, China., Du LF; The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China.; National Engineering Center for New Vaccine Research, Beijing, China., Tang F; The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China.; National Engineering Center for New Vaccine Research, Beijing, China., Chen S; The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China.; National Engineering Center for New Vaccine Research, Beijing, China., Ma ZJ; The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China.; National Engineering Center for New Vaccine Research, Beijing, China., Zheng F; The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China.; National Engineering Center for New Vaccine Research, Beijing, China., Hou YN; The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China.; National Engineering Center for New Vaccine Research, Beijing, China., Li XY; The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China.; National Engineering Center for New Vaccine Research, Beijing, China., Li X; The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China.; National Engineering Center for New Vaccine Research, Beijing, China., Wang ZN; China National Biotec Group Company Limited, Beijing, China., Yin JL; China National Biotec Group Company Limited, Beijing, China., Mao XY; Lanzhou Institute of Biological Products Company Limited, Lanzhou, China., Zhang J; Beijing Institute of Biological Products Company Limited, Beijing, China., Qu L; China National Biotec Group Company Limited, Beijing, China., Zhang YT; China National Biotec Group Company Limited, Beijing, China. zhangyuntao@sinopharm.com., Yang XM; China National Biotec Group Company Limited, Beijing, China. yangxiaoming@sinopharm.com., Wu G; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), Beijing, China. wugz@ivdc.chinacdc.cn., Li QM; The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China. liqiming189@163.com.; National Engineering Center for New Vaccine Research, Beijing, China. liqiming189@163.com.

Publikováno v: Signal transduction and targeted therapy [Signal Transduct Target Ther] 2023 Jan 03; Vol. 8 (1), pp. 20. Date of Electronic Publication: 2023 Jan 03.

Immunogenicity and safety of NVSI-06-07 as a heterologous booster after priming with BBIBP-CorV: a phase 2 trial.

Autor: Kaabi NA; Sheikh Khalifa Medical City, SEHA, Abu Dhabi, United Arab Emirates.; College of Medicine and Health Sciences, Khalifa University, Abu Dhabi, United Arab Emirates., Yang YK; China National Biotec Group Company Limited, Beijing, China., Zhang J; The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China.; National Engineering Center for New Vaccine Research, Beijing, China., Xu K; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), Beijing, China., Liang Y; The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China.; National Engineering Center for New Vaccine Research, Beijing, China., Kang Y; The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China.; National Engineering Center for New Vaccine Research, Beijing, China., Su JG; The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China.; National Engineering Center for New Vaccine Research, Beijing, China., Yang T; China National Biotec Group Company Limited, Beijing, China., Hussein S; Sheikh Khalifa Medical City, SEHA, Abu Dhabi, United Arab Emirates., ElDein MS; Sheikh Khalifa Medical City, SEHA, Abu Dhabi, United Arab Emirates., Shao S; The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China.; National Engineering Center for New Vaccine Research, Beijing, China., Yang SS; The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China.; National Engineering Center for New Vaccine Research, Beijing, China., Lei W; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), Beijing, China., Gao XJ; Lanzhou Institute of Biological Products Company Limited, Lanzhou, China., Jiang Z; Beijing Key Tech Statistical Consulting Co., Ltd, Beijing, China., Wang H; Beijing Institute of Biological Products Company Limited, Beijing, China., Li M; China National Biotec Group Company Limited, Beijing, China., Mekki HM; Union 71, Abu Dhabi, United Arab Emirates., Zaher W; G42 Healthcare, Abu Dhabi, United Arab Emirates., Mahmoud S; G42 Healthcare, Abu Dhabi, United Arab Emirates., Zhang X; China National Biotec Group Company Limited, Beijing, China., Qu C; China National Biotec Group Company Limited, Beijing, China., Liu DY; China National Biotec Group Company Limited, Beijing, China., Zhang J; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), Beijing, China., Yang M; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), Beijing, China., Eltantawy I; G42 Healthcare, Abu Dhabi, United Arab Emirates., Xiao P; G42 Healthcare, Abu Dhabi, United Arab Emirates., Wang ZN; China National Biotec Group Company Limited, Beijing, China., Yin JL; China National Biotec Group Company Limited, Beijing, China., Mao XY; Lanzhou Institute of Biological Products Company Limited, Lanzhou, China., Zhang J; Beijing Institute of Biological Products Company Limited, Beijing, China., Liu N; The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China.; National Engineering Center for New Vaccine Research, Beijing, China., Shen FJ; The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China.; National Engineering Center for New Vaccine Research, Beijing, China., Qu L; China National Biotec Group Company Limited, Beijing, China., Zhang YT; China National Biotec Group Company Limited, Beijing, China. zhangyuntao@sinopharm.com., Yang XM; China National Biotec Group Company Limited, Beijing, China. yangxiaoming@sinopharm.com., Wu G; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), Beijing, China. wugz@ivdc.chinacdc.cn., Li QM; The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing, China. liqiming189@163.com.; National Engineering Center for New Vaccine Research, Beijing, China. liqiming189@163.com.

Publikováno v: Signal transduction and targeted therapy [Signal Transduct Target Ther] 2022 Jun 06; Vol. 7 (1), pp. 172. Date of Electronic Publication: 2022 Jun 06.

Fine-Needle Aspiration Cytology of Follicular Dendritic Cell Sarcoma of Cervical Lymph Node: A Challenging Diagnosis.

Autor: Abdou AG; Department of Pathology, Faculty of Medicine, Menoufia University, Shebein Elkom, Egypt., Asaad N; Department of Pathology, Faculty of Medicine, Menoufia University, Shebein Elkom, Egypt., Aiad H; Department of Pathology, Faculty of Medicine, Menoufia University, Shebein Elkom, Egypt., Shams A; Department of Pathology, Faculty of Medicine, Menoufia University, Shebein Elkom, Egypt., Said A; Department of Pathology, Faculty of Medicine, Menoufia University, Shebein Elkom, Egypt., Eldein MS; Department of Pathology, Faculty of Medicine, Menoufia University, Shebein Elkom, Egypt.

Publikováno v: Journal of microscopy and ultrastructure [J Microsc Ultrastruct] 2019 Jul-Sep; Vol. 7 (3), pp. 143-145.